ANNEX I, Regulation (EU) 2015/2105

In forcesince 20 Nov 2015

[Further details on identity and specification of active substance are provided in the review report.]

Common Name, Identification Numbers | IUPAC Name | Purity | Date of approval | Expiration of approval | Specific provisions

Flumetralin

CAS No 62924-70-3

CIPAC No 971

N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine |

980 g/kg

The impurity Nitrosamine (calculated as nitroso-dimethylamine) shall not exceed 0,001 g/kg in the technical material.

11 December 2015 | 11 December 2022 |

For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on flumetralin, and in particular Appendices I and II thereof, shall be taken into account.

In this overall assessment Member States shall pay particular attention to:

(a)

the protection of operators and workers, ensuring that conditions of use include the application of adequate personal protective equipment, where appropriate;

(b)

the protection of groundwater, when the substance is applied in regions with vulnerable soil and/or climatic conditions;

(c)

the risk to herbivorous mammals;

(d)

the risk to aquatic organisms.

Conditions of use shall include risk mitigation measures, where appropriate.

The applicant shall submit confirmatory information as regards:

1.

the technical specification of the active substance as manufactured (based on commercial scale production);

2.

the compliance of the toxicity batches with the confirmed technical specification.

The applicant shall submit to the Commission, the Member States and the Authority the information referred to in points 1 and 2 by 11 June 2016.